19/DRA/DC/Notification/2016-2017/40

Regulatory Notification

DRA would like to notify that the application fee for product dossier assessment has been revised to Nu. 500 (Five hundred) based on the consensus of the stakeholders and approval from the Sixteenth meeting of the Bhutan Medicines Board. This is notification shall come into force from 03 August, 2017.

Please click on the link below to view the Notification:

• Notification on the change of Application fee for Product dossier assessment